Intuitive Surgical Inc (ISRG)
547.87
-2.75
(-0.50%)
USD |
NASDAQ |
Nov 22, 16:00
548.60
+0.73
(+0.13%)
After-Hours: 20:00
Intuitive Surgical Free Cash Flow: 586.00M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 586.00M |
| June 30, 2024 | 419.50M |
| March 31, 2024 | 595.80M |
| December 31, 2023 | 749.60M |
| September 30, 2023 | 1.256B |
| June 30, 2023 | 1.178B |
| March 31, 2023 | 1.006B |
| December 31, 2022 | 958.40M |
| September 30, 2022 | 1.090B |
| June 30, 2022 | 1.310B |
| March 31, 2022 | 1.460B |
| December 31, 2021 | 1.750B |
| September 30, 2021 | 1.885B |
| June 30, 2021 | 1.662B |
| March 31, 2021 | 1.315B |
| December 31, 2020 | 1.143B |
| September 30, 2020 | 988.40M |
| June 30, 2020 | 1.088B |
| March 31, 2020 | 1.202B |
| December 31, 2019 | 1.173B |
| September 30, 2019 | 1.044B |
| June 30, 2019 | 1.008B |
| March 31, 2019 | 960.50M |
| December 31, 2018 | 982.20M |
| September 30, 2018 | 1.001B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.030B |
| March 31, 2018 | 1.005B |
| December 31, 2017 | 953.20M |
| September 30, 2017 | 964.10M |
| June 30, 2017 | 915.30M |
| March 31, 2017 | 1.004B |
| December 31, 2016 | 1.033B |
| September 30, 2016 | 1.019B |
| June 30, 2016 | 916.70M |
| March 31, 2016 | 837.90M |
| December 31, 2015 | 725.20M |
| September 30, 2015 | 556.20M |
| June 30, 2015 | 541.80M |
| March 31, 2015 | 505.80M |
| December 31, 2014 | 559.50M |
| September 30, 2014 | 630.70M |
| June 30, 2014 | 663.70M |
| March 31, 2014 | 692.30M |
| December 31, 2013 | 775.40M |
| September 30, 2013 | 731.30M |
| June 30, 2013 | 786.00M |
| March 31, 2013 | 824.60M |
| December 31, 2012 | 700.00M |
| September 30, 2012 | 742.40M |
| June 30, 2012 | 661.00M |
Free Cash Flow Range, Past 5 Years
419.50M
Minimum
Jun 2024
1.885B
Maximum
Sep 2021
1.141B
Average
1.158B
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 6.486B |
| Becton Dickinson & Co | 3.073B |
| Masimo Corp | 149.60M |
| PROCEPT BioRobotics Corp | -103.56M |
| Perspective Therapeutics Inc | -40.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 706.50M |
| Cash from Investing (Quarterly) | -1.413B |
| Cash from Financing (Quarterly) | 98.20M |
| Free Cash Flow Per Share (Quarterly) | 1.264 |
| Free Cash Flow to Equity (Quarterly) | 458.60M |
| Free Cash Flow to Firm (Quarterly) | 458.60M |
| Free Cash Flow Yield | 0.30% |